Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 1/20 | 0.77 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.74 |
| ▸ | ATM | Q13315 | 1/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | THRB | P10828 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | CA1 | P00915 | 4/20 | 0.51 |
| ▸ | CA2 | P00918 | 4/20 | 0.51 |
| ▸ | CA9 | Q16790 | 4/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | GLA | P06280 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30174104 | 0.92 | CHRM1 (0.83) | CHRM1MAPK1ATMALDH1A1LMNA | |
| SCHEMBL7713064 | 0.88 | CHRM1 (0.77) | CHRM1MAPK1ATMALDH1A1LMNA | |
| Ornidazole SCHEMBL15158379 | 0.87 | CHRM1 (1.00) | CHRM1MAPK1ATMALDH1A1LMNA | |
| Ornidazole SCHEMBL43039 | 0.87 | CHRM1 (1.00) | CHRM1MAPK1ATMALDH1A1LMNA | |
| SCHEMBL27714481 | 0.87 | CHRM1 (0.75) | CHRM1MAPK1ATMALDH1A1LMNA | |
| SCHEMBL25121459 | 0.87 | CHRM1 (0.75) | CHRM1MAPK1ATMALDH1A1LMNA | |
| SCHEMBL16367304 | 0.87 | CHRM1 (0.75) | CHRM1MAPK1ATMALDH1A1LMNA | |
| SCHEMBL16367305 | 0.87 | CHRM1 (0.75) | CHRM1MAPK1ATMALDH1A1LMNA | |
| Ornidazole SCHEMBL15158378 | 0.87 | CHRM1 (1.00) | CHRM1MAPK1ATMALDH1A1LMNA | |
| SCHEMBL25727284 | 0.87 | CHRM1 (0.75) | CHRM1MAPK1ATMALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115976586-A | Positive and negative pulse electrolytic nickel-tungsten alloy solution, preparation method, electroplating method and nickel-tungsten alloy coating | 昆山一鼎工业科技有限公司 | 2023-04-18 | — | — | CN | claimed |
| CN-115561347-A | High performance liquid chromatography detection method for related substances of morpholine ornidazole raw material medicine | 山东齐都药业有限公司 | 2023-01-03 | — | — | CN | claimed |
| CN-112213407-B | Detection method of levoornidazole related substances | 南京卡文迪许生物工程技术有限公司 | 2022-08-09 | — | — | CN | claimed |
| WO-2021058014-A1 | ORNIDAZOLE PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD AND USE THEREOF | 扬子江药业集团南京海陵药业有限公司 | 2021-04-01 | — | — | WO | claimed |
| CN-112569229-A | Preparation containing ornidazole compound and preparation method and application thereof | 扬子江药业集团南京海陵药业有限公司 | 2021-03-30 | — | — | CN | claimed |
| CN-112569230-A | Ornidazole pharmaceutical composition with high safety as well as preparation method and application thereof | 扬子江药业集团南京海陵药业有限公司 | 2021-03-30 | — | — | CN | claimed |
| CN-112569228-A | Pharmaceutical composition containing ornidazole compounds and preparation method and application thereof | 扬子江药业集团南京海陵药业有限公司 | 2021-03-30 | — | — | CN | claimed |
| CN-115976586-B | Forward and reverse pulse electrolytic nickel-tungsten alloy solution, preparation method, electroplating method and nickel-tungsten alloy coating | 昆山一鼎工业科技有限公司 | 2025-03-14 | — | — | CN | disclosed |
| CN-116448935-A | High performance liquid chromatography for simultaneously detecting and separating five high concentration ornidazole injection impurities | 山东海雅医药科技有限公司 | 2023-07-18 | — | — | CN | disclosed |
| CN-115976586-A | Positive and negative pulse electrolytic nickel-tungsten alloy solution, preparation method, electroplating method and nickel-tungsten alloy coating | 昆山一鼎工业科技有限公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-113759002-B | Separation and detection method for isomers in levoornidazole or precursor compound thereof | 扬子江药业集团南京海陵药业有限公司 | 2023-03-24 | — | — | CN | disclosed |
| CN-115561347-A | High performance liquid chromatography detection method for related substances of morpholine ornidazole raw material medicine | 山东齐都药业有限公司 | 2023-01-03 | — | — | CN | disclosed |
| CN-112213407-B | Detection method of levoornidazole related substances | 南京卡文迪许生物工程技术有限公司 | 2022-08-09 | — | — | CN | disclosed |
| CN-110917135-A | Solvent system capable of effectively dissolving ornidazole or levoornidazole and injection thereof | 西南大学 | 2020-03-27 | — | — | CN | disclosed |
| CN-101239951-B | 1-(2,3-dihydroxypropyl)-2-methyl-5-nitroimidazole compound and its preparation method and use | SICHUAN BAILI PHARMACEUTICAL CO LTD | 2011-01-26 | — | — | CN | disclosed |
| CN-101239951-B | 1-(2,3-dihydroxypropyl)-2-methyl-5-nitroimidazole compound and its preparation method and use | SICHUAN BAILI PHARMACEUTICAL CO LTD | 2011-01-26 | — | — | CN | disclosed |
| CN-101239951-A | 1-(2,3-dihydroxypropyl)-2-methyl-5-nitroimidazole compound and its preparation method and use | SICHUAN BAILI PHARMACEUTICAL C (CN) | 2008-08-13 | — | — | CN | disclosed |
| CN-101239951-A | 1-(2,3-dihydroxypropyl)-2-methyl-5-nitroimidazole compound and its preparation method and use | SICHUAN BAILI PHARMACEUTICAL C (CN) | 2008-08-13 | — | — | CN | disclosed |
| US-7238212-B2 | Imidazole compounds and use of these compounds for dyeing keratinous fibers | L'OREAL, S.A. (FR) | 2007-07-03 | — | — | US | disclosed |
| US-20050011019-A1 | Novel imidazole compounds and use of these compounds for dyeing keratinous fibers | L'OREAL, S.A. (FR) | 2005-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050011019-A1 | Novel imidazole compounds and use of these compounds for dyeing keratinous fibers | KRT18, VIM, NDUFS6 | CHRM1 2225/4885MAPK1 2658/4885ATM 693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.